A growing number of studies suggested that CD146 overexpression was significantly correlated with progression, angiogenesis, and metastasis of different malignant tumors like esophageal cancer, melanoma, gallbladder adenocarcinoma, ovarian carcinoma, and prostate cancer [6–12]. The gene discussed is MCAM; the disease is cancer.